tiprankstipranks
Trending News
More News >

Haleon PLC Executes Share Buyback to Enhance Shareholder Value

Story Highlights
  • Haleon PLC purchased 1,009,135 shares for cancellation under its buyback program.
  • The share buyback aligns with Haleon’s strategic financial management to optimize shareholder value.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Haleon PLC Executes Share Buyback to Enhance Shareholder Value

Don’t Miss TipRanks’ Half Year Sale

Haleon PLC Sponsored ADR ( (HLN) ) just unveiled an update.

On June 25, 2025, Haleon PLC announced the purchase and cancellation of 1,009,135 ordinary shares as part of its share buyback program initiated on March 28, 2025. This transaction, completed on June 24, 2025, reflects Haleon’s strategic financial management to optimize shareholder value. The company’s registered share capital now stands at 8,989,539,664 ordinary shares, with 8,985,459,459 shares carrying voting rights. This move is expected to impact shareholder interests and aligns with regulatory requirements under the UK’s Market Abuse Regulation.

The most recent analyst rating on (HLN) stock is a Buy with a $13.40 price target. To see the full list of analyst forecasts on Haleon PLC Sponsored ADR stock, see the HLN Stock Forecast page.

Spark’s Take on HLN Stock

According to Spark, TipRanks’ AI Analyst, HLN is a Outperform.

Haleon’s strong financial performance, characterized by robust cash flow and stable profitability, is a key strength, complemented by positive technical indicators suggesting upward momentum. However, the stock’s valuation appears high, and recent earnings call highlights both opportunities in emerging markets and challenges like FX headwinds and product performance issues. These factors collectively position the stock at a solid yet cautious 73.1 score.

To see Spark’s full report on HLN stock, click here.

More about Haleon PLC Sponsored ADR

Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with a human touch. The company’s product portfolio includes six major categories: Oral Health, Vitamins, Minerals and Supplements, Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. Haleon is known for its trusted brands such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu, and Voltaren.

Average Trading Volume: 16,165,573

Technical Sentiment Signal: Buy

Current Market Cap: $47.03B

For an in-depth examination of HLN stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1